Dr. Sachin Wadhawan, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,788 | 264 | 98.7% |
| Education | $62.67 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $906.87 | 56 | $0 (2024) |
| PFIZER INC. | $557.99 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $429.38 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $392.74 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $326.74 | 18 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $320.98 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $269.48 | 20 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $266.43 | 9 | $0 (2024) |
| Edwards Lifesciences Corporation | $213.10 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $143.46 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,137 | 47 | Novartis Pharmaceuticals Corporation ($194.45) |
| 2023 | $944.76 | 49 | Amgen Inc. ($180.24) |
| 2022 | $719.76 | 41 | Amgen Inc. ($139.19) |
| 2021 | $140.42 | 6 | iRhythm Technologies, Inc. ($69.43) |
| 2020 | $87.97 | 6 | Amgen Inc. ($30.15) |
| 2019 | $604.97 | 39 | Amgen Inc. ($243.46) |
| 2018 | $749.19 | 49 | Boehringer Ingelheim Pharmaceuticals, Inc. ($161.79) |
| 2017 | $467.11 | 33 | Amgen Inc. ($77.44) |
All Payment Transactions
270 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/02/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $52.90 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Cardiovascular | ||||||
| 08/22/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: DIABETES | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $116.10 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $6.40 | General |
| Category: Cardiology | ||||||
| 06/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Cardiovascular | ||||||
| 06/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,077 | 1,281 | $150,126 | $53,735 |
| 2022 | 18 | 1,134 | 1,329 | $156,393 | $59,816 |
| 2021 | 19 | 1,124 | 1,359 | $161,976 | $66,748 |
| 2020 | 23 | 1,122 | 1,317 | $156,479 | $64,221 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 227 | $32,910 | $19,938 | 60.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 169 | 176 | $23,104 | $8,539 | 37.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 80 | 80 | $12,000 | $4,411 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $9,165 | $4,323 | 47.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 49 | 52 | $13,276 | $4,216 | 31.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 216 | 277 | $11,080 | $2,817 | 25.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 20 | $3,600 | $2,011 | 55.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 22 | 35 | $4,375 | $1,911 | 43.7% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 20 | 31 | $2,015 | $1,240 | 61.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 68 | 70 | $2,179 | $1,006 | 46.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 12 | 29 | $3,625 | $706.50 | 19.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 68 | 70 | $16,398 | $652.93 | 4.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 67 | 72 | $2,772 | $423.64 | 15.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 14 | 21 | $1,470 | $414.72 | 28.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 31 | 31 | $9,393 | $380.43 | 4.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 12 | 24 | $1,440 | $341.20 | 23.7% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 13 | 13 | $975.00 | $204.79 | 21.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 13 | 14 | $350.00 | $200.20 | 57.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 254 | $36,825 | $21,177 | 57.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 201 | 212 | $27,829 | $10,207 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $12,455 | $5,861 | 47.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 66 | 67 | $10,050 | $3,962 | 39.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 31 | 31 | $5,580 | $3,253 | 58.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 216 | 252 | $10,099 | $2,486 | 24.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 21 | 37 | $4,625 | $2,128 | 46.0% |
About Dr. Sachin Wadhawan, M.D
Dr. Sachin Wadhawan, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1700023579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sachin Wadhawan, M.D has received a total of $4,851 in payments from pharmaceutical and medical device companies, with $1,137 received in 2024. These payments were reported across 270 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,788).
As a Medicare-enrolled provider, Wadhawan has provided services to 4,457 Medicare beneficiaries, totaling 5,286 services with total Medicare billing of $244,521. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Cardiovascular Disease, Nuclear Cardiology
- Location Buffalo, NY
- Active Since 01/14/2009
- Last Updated 08/21/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700023579
Products in Payments
- Repatha (Biological) $711.50
- ELIQUIS (Drug) $574.25
- XARELTO (Drug) $326.74
- JARDIANCE (Drug) $280.96
- Assure WCD (Device) $266.43
- LEQVIO (Drug) $251.05
- Corlanor (Drug) $195.37
- SAPIEN 3 Ultra RESILIA (Device) $150.83
- CHANTIX (Drug) $148.43
- PRADAXA (Drug) $148.42
- PRALUENT (Drug) $143.46
- ENTRESTO (Drug) $141.69
- BRILINTA (Drug) $138.95
- LifeVest (Device) $126.72
- Barostim Neo System (Device) $116.10
- CAMZYOS (Drug) $96.70
- FARXIGA (Drug) $89.38
- PRALUENT ALIROCUMAB INJECTION (Biological) $71.59
- ZIO Patch (Device) $69.43
- NEXLETOL (Drug) $54.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Buffalo
Sandra Sieminski, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $64,808
Carter Lindborg, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,328
Dr. Thomas Suchy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,872
Paola Ghione, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,368
Vincent Croglio, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,454
Steven Green, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,842